Vasopressor potentiation of neurotoxicity in experimental aortography. Implications regarding pathogenesis of contrast medium injury.
D000818:Animals; D001027:Aortography / Q000009:adverse effects*; D003287:Contrast Media / Q000009:adverse effects*; D004285:Dogs; D008619:Mepivacaine / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D010243:Paralysis / Q000209:etiology*; D012640:Seizures / Q000209:etiology*; D013118:Spinal Cord Diseases / Q000209:etiology*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*
D003287:Contrast Media; D014662:Vasoconstrictor Agents; D008619:Mepivacaine; D009638:Norepinephrine